We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$16.7M
Cap. Flow
+$30.5M
Cap. Flow %
2.69%
Top 10 Hldgs %
27.68%
Holding
528
New
41
Increased
251
Reduced
124
Closed
40

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 18.17%
3 Healthcare 7.94%
4 Consumer Discretionary 4.92%
5 Communication Services 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
476
Teva Pharmaceuticals
TEVA
$40.8B
$88K 0.01%
10,950
-150
-1% -$1.35K
SNCR
477
DELISTED
Synchronoss Technologies
SNCR
$74K 0.01%
3,392
SWN
478
DELISTED
Southwestern Energy Company
SWN
$68K 0.01%
14,681
CFRX
479
DELISTED
ContraFect Corporation
CFRX
$58K 0.01%
278
APPH
480
DELISTED
AppHarvest, Inc. Common Stock
APPH
$49K ﹤0.01%
12,500
-12,580
-50% -$67.2K
APTO
481
DELISTED
Aptose Biosciences, Inc.
APTO
$32K ﹤0.01%
53
GSV
482
DELISTED
Gold Standard Ventures Corp.
GSV
$31K ﹤0.01%
70,000
-172,341
-71% -$79.5K
ELVT
483
DELISTED
Elevate Credit, Inc.
ELVT
$30K ﹤0.01%
10,000
IVR icon
484
Invesco Mortgage Capital
IVR
$759M
$28K ﹤0.01%
1,012
SNDL icon
485
Sundial Growers
SNDL
$320M
$23K ﹤0.01%
4,000
CELG.RT
486
Bristol-Myers Squibb Rights
CELG.RT
$191M
$22K ﹤0.01%
117,775
OTLK icon
487
Outlook Therapeutics
OTLK
$183M
$14K ﹤0.01%
+500
New +$17.8K
CALA
488
DELISTED
Calithera Biosciences, Inc
CALA
$10K ﹤0.01%
739
-750
-50% -$18.8K
AAXJ icon
489
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.68B
-22,729
Closed -$2M
AGZ icon
490
iShares Agency Bond ETF
AGZ
$558M
-1,846
Closed -$218K
ARKW icon
491
ARK Web x.0 ETF
ARKW
$1.63B
-1,977
Closed -$310K
BIDU icon
492
Baidu
BIDU
$37.7B
-2,150
Closed -$363K
BKD icon
493
Brookdale Senior Living
BKD
$3.49B
-68,115
Closed -$443K
BSV icon
494
Vanguard Short-Term Bond ETF
BSV
$44.7B
-3,379
Closed -$275K
CCL icon
495
Carnival Corporation Ltd
CCL
$38.1B
-22,266
Closed -$486K
CRSP icon
496
CRISPR Therapeutics
CRSP
$4.73B
-2,222
Closed -$211K
CSQ icon
497
Calamos Strategic Total Return Fund
CSQ
$3.23B
-10,705
Closed -$201K
DMO
498
Western Asset Mortgage Opportunity Fund
DMO
$118M
-14,994
Closed -$236K
FINX icon
499
Global X FinTech ETF
FINX
$170M
-4,600
Closed -$241K
FL
500
DELISTED
Foot Locker
FL
-5,300
Closed -$256K

Similar funds

Transcend Capital Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Transcend Capital Advisors held 528 positions worth $1.13B, up 1.5% from $1.12B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Transcend Capital Advisors's Q4 2021 filing shows 41 new, 251 increased, 124 reduced and 40 closed positions. Its largest new stake was ITT: 21,295 shares worth $2.18M. The largest sale was Intercontinental Exchange, an estimated $3.86M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Transcend Capital Advisors's largest Q4 2021 buy was ITT: 21,295 shares worth $2.18M.
  • Transcend Capital Advisors added most to Microsoft in Q4 2021, an estimated $3.36M increase.
  • Transcend Capital Advisors's biggest Q4 2021 reduction was Intercontinental Exchange, cutting an estimated $3.86M.
  • Transcend Capital Advisors fully exited Quadratic Interest Rate Volatility and Inflation Hedge ETF in Q4 2021, selling an estimated $2.1M.
  • Transcend Capital Advisors's ten largest holdings make up 28% of its $1.13B portfolio in Q4 2021.
  • Transcend Capital Advisors opened 41 new positions and closed 40 in Q4 2021.
  • Transcend Capital Advisors's portfolio value rose 1.5% quarter-over-quarter to $1.13B.

Based on Transcend Capital Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.